Frankfurt - Delayed Quote EUR
Alterity Therapeutics Limited (PBN.F)
0.0045
+0.0005
+(12.50%)
At close: April 25 at 8:02:34 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
Gozlan (Lawrence) Director (Non-Executive) | Other | Apr 7, 2025 | 4,545,455 |
Marks (Peter Vincent) Independent Non-Executive Director | Other | Apr 7, 2025 | 9,004,150 |
Meltzer (Brian Derek) Independent Non-Executive Director | Other | Apr 7, 2025 | 9,742,250 |
Stamler (David) Chief Executive Officer | Other | Jun 30, 2024 | 10,697,857 |
Related Tickers
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
6XY.F HBM Holdings Limited
0.9000
+5.88%
FAB.L Fusion Antibodies plc
6.80
-9.09%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
MDCLF MedinCell S.A.
6.98
0.00%